Blood test study for early cancer detection in patients
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You can read and understand English or Spanish
- You can safely have about 60 mL of blood drawn for research
- You are not currently pregnant (by self-report)
- If you have cancer: you have a confirmed invasive cancer diagnosis and no prior anti-cancer treatment
- If you don’t have a diagnosis: you have no suspicion of cancer, or you are being worked up for specific cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that may help find cancer early. You will give blood samples over a year, and researchers will check them for signs of cancer.
This study is testing whether simple blood, tissue, and urine samples can help find cancer earlier and identify where it started. Participating could help improve future cancer detection for everyone.
This study is testing a new blood test to look for early signs of cancer in people without a past cancer diagnosis. You would give blood, urine, and saliva samples to help researchers see if the test works well.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.